Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1949 1
1952 1
1954 3
1955 3
1956 3
1957 3
1958 2
1959 4
1960 2
1961 1
1962 2
1963 5
1964 2
1965 1
1967 1
1968 3
1969 2
1972 3
1973 2
1974 1
1976 2
1977 2
1981 1
1982 2
1983 1
1985 1
1986 2
1987 2
1988 1
1989 1
1990 3
1993 2
1994 2
1995 2
1997 2
1998 3
1999 1
2002 1
2005 1
2006 3
2007 3
2008 4
2009 2
2010 2
2011 3
2012 5
2013 7
2014 7
2015 2
2016 4
2017 7
2018 5
2019 3
2020 5
2021 10
2022 4
2023 7
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

151 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean acquired factor x deficiency (123 results)?
Disorders of Fibrinogen and Fibrinolysis.
May JE, Wolberg AS, Lim MY. May JE, et al. Hematol Oncol Clin North Am. 2021 Dec;35(6):1197-1217. doi: 10.1016/j.hoc.2021.07.011. Epub 2021 Aug 14. Hematol Oncol Clin North Am. 2021. PMID: 34404562 Free PMC article. Review.
This review summarizes (i) the basic elements of fibrin(ogen) and its role in coagulation and the fibrinolytic system; (ii) the laboratory evaluation for fibrin(ogen) disorders, including the use of global fibrinolysis assays; and (iii) the management of congenital and acquire …
This review summarizes (i) the basic elements of fibrin(ogen) and its role in coagulation and the fibrinolytic system; (ii) the laboratory e …
Thrombotic microangiopathy due to acquired complement factor I deficiency in a male receiving interferon-beta treatment for multiple sclerosis.
Mrabet S, Dahmane R, Raja B, Fradi A, Aicha NB, Sahtout W, Azzabi A, Guedri Y, Zellama D, Achour A, Sfar I, Goucha R, Abdessayed N, Mokni M. Mrabet S, et al. Br J Clin Pharmacol. 2023 May;89(5):1682-1685. doi: 10.1111/bcp.15631. Epub 2022 Dec 23. Br J Clin Pharmacol. 2023. PMID: 36480744
Nonetheless, the patient remained hemodialysis-dependent. Exploration of the complement system found a complement factor I deficiency whose activity normalized at the control carried out after 2 years. ...
Nonetheless, the patient remained hemodialysis-dependent. Exploration of the complement system found a complement factor I …
Secondary IGF-I deficiency as a prognostic factor of growth hormone (GH) therapy effectiveness in children with isolated, non-acquired GH deficiency.
Smyczyńska J, Stawerska R, Hilczer M, Lewiński A. Smyczyńska J, et al. Exp Clin Endocrinol Diabetes. 2015 Apr;123(4):209-14. doi: 10.1055/s-0034-1395665. Epub 2015 Jan 21. Exp Clin Endocrinol Diabetes. 2015. PMID: 25607339
PATIENTS AND METHODS: The analysis comprised 300 children with isolated, non-acquired GHD (GH peak below 10 mug/l) who completed GH therapy and attained final height (FH). ...The patients with deltaHSDS over the median value had significantly lower IGF-I SDS than those wit …
PATIENTS AND METHODS: The analysis comprised 300 children with isolated, non-acquired GHD (GH peak below 10 mug/l) who completed GH t …
Cryoprecipitate: an outmoded treatment?
Yang L, Stanworth S, Baglin T. Yang L, et al. Transfus Med. 2012 Oct;22(5):315-20. doi: 10.1111/j.1365-3148.2012.01181.x. Transfus Med. 2012. PMID: 22994448 Review.
Now, the most common use of cryoprecipitate is fibrinogen replacement in patients with acquired hypofibrinogenaemia and bleeding. Despite almost 50 years of use, evidence of efficacy is limited. ...
Now, the most common use of cryoprecipitate is fibrinogen replacement in patients with acquired hypofibrinogenaemia and bleeding. Des …
Thrombin clotting time.
Ignjatovic V. Ignjatovic V. Methods Mol Biol. 2013;992:131-8. doi: 10.1007/978-1-62703-339-8_10. Methods Mol Biol. 2013. PMID: 23546710
Thrombin clotting time (TCT) is a coagulation assay used to diagnose congenital and acquired fibrinogen deficiency (Adcock et al., Coagulation handbook, Esoterix Coagulation, Austin, TX, 2002), as well as to identify contamination by heparin, prior to performing additional …
Thrombin clotting time (TCT) is a coagulation assay used to diagnose congenital and acquired fibrinogen deficiency (Adcock et al., Co …
Inherited thrombophilia.
Franchini M, Veneri D, Salvagno GL, Manzato F, Lippi G. Franchini M, et al. Crit Rev Clin Lab Sci. 2006;43(3):249-90. doi: 10.1080/10408360600552678. Crit Rev Clin Lab Sci. 2006. PMID: 16574555 Review.
In this review, the main inherited prothrombotic risk factors are analyzed from epidemiological, laboratory, clinical, and therapeutic points of view. Finally, we discuss the synergism between genetic and acquired prothrombotic risk factors in particular conditions such as …
In this review, the main inherited prothrombotic risk factors are analyzed from epidemiological, laboratory, clinical, and therapeutic point …
Congenital dysfibrinogenemia.
Martinez J. Martinez J. Curr Opin Hematol. 1997 Sep;4(5):357-65. doi: 10.1097/00062752-199704050-00010. Curr Opin Hematol. 1997. PMID: 9288470 Review.
Fibrinogen abnormalities can be classified as congenital or acquired. Each class manifests quantitative or qualitative alterations; the latter are known as dysfibrinogenemias. ...
Fibrinogen abnormalities can be classified as congenital or acquired. Each class manifests quantitative or qualitative alterations; t …
Long-term treatment with recombinant insulin-like growth factor (IGF)-I in children with severe IGF-I deficiency due to growth hormone insensitivity.
Chernausek SD, Backeljauw PF, Frane J, Kuntze J, Underwood LE; GH Insensitivity Syndrome Collaborative Group. Chernausek SD, et al. J Clin Endocrinol Metab. 2007 Mar;92(3):902-10. doi: 10.1210/jc.2006-1610. Epub 2006 Dec 27. J Clin Endocrinol Metab. 2007. PMID: 17192294 Clinical Trial.
CONTEXT: Children with severe IGF-I deficiency due to congenital or acquired defects in GH action have short stature that cannot be remedied by GH treatment. ...
CONTEXT: Children with severe IGF-I deficiency due to congenital or acquired defects in GH action have short stature that cannot be r …
Acquired factor V and factor X Deficiency coexisting with acquired dysfibrinogenaemia in a patient with light chain myeloma.
Jeffrey S, Hamilton C, Ames PRJ. Jeffrey S, et al. Blood Coagul Fibrinolysis. 2024 Apr 1;35(3):139-140. doi: 10.1097/MBC.0000000000001280. Epub 2024 Feb 7. Blood Coagul Fibrinolysis. 2024. PMID: 38358896
We wish to describe the unusual association of FX and FV deficiency co-existing with an acquired dysfibrinogenaemia....
We wish to describe the unusual association of FX and FV deficiency co-existing with an acquired dysfibrinogenaemia....
151 results